Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 10/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.62 |
| ▸ | RAD52 | P43351 | 1/20 | 0.62 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.61 |
| ▸ | LSS | P48449 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28857902 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL5086721 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL7152946 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL240975 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL1306021 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL4347940 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL10695829 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL853784 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL20504226 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 | |
| Bromide SCHEMBL1502887 | 1.00 | DNM1 (0.68) | DNM1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570492-A | AT cut quartz single crystal water system corrosive liquid | 湖北兴福电子材料股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119752507-A | Graphene oxide-based lubricating oil additive and preparation method thereof | 华南理工大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-119570492-A | AT cut quartz single crystal water system corrosive liquid | 湖北兴福电子材料股份有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-112011006-B | High-absorptivity resin for removing adult urine odor and preparation method thereof | 浙江卫星新材料科技有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-112011006-A | High-absorptivity resin for removing adult urine odor and preparation method thereof | 浙江卫星新材料科技有限公司 | 2020-12-01 | — | — | CN | disclosed |
| US-8409554-B2 | Aqueous mixture of a mono C14-C22 trimethylammonium cationic surfactant, a di-(C20-C24) imidazoline quaternary surfactant, and a mono C12-C22 alkyl hydroxyethyl dimethylammonium surfactant; hair conditioners; smoothness, softness, manageability, cuticle integrity, antistatic agents and shine | CONOPCO, INC. (US) | 2013-04-02 | — | — | US | disclosed |
| WO-2012004811-A1 | PROCESS FOR THE PREPARATION OF 5-SUBSTSITUTED INDOLE DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2012-01-12 | — | — | WO | disclosed |
| US-20080233070-A1 | Hair Treatment Compositions | CONOPCO, INC. D/B/A UNILEVER | 2008-09-25 | — | — | US | disclosed |
| EP-1680075-B1 | HAIR CONDITIONING COMPOSITIONS | UNILEVER PLC (GB) | 2008-01-02 | — | — | EP | disclosed |
| EP-1725212-B1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-06-27 | — | — | EP | disclosed |
| EP-1680075-A1 | HAIR CONDITIONING COMPOSITIONS | UNILEVER PLC (GB) | 2006-07-19 | — | — | EP | disclosed |
| US-20050232892-A1 | Hair conditioning composition | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-10-20 | — | — | US | disclosed |
| WO-2005039517-A1 | HAIR CONDITIONING COMPOSITIONS | UNILEVER PLC (GB) | 2005-05-06 | — | — | WO | disclosed |
| EP-1515689-A1 | HAIR CONDITIONING COMPOSITION | UNILEVER PLC (GB) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000250-A1 | HAIR CONDITIONING COMPOSITION | UNILEVER PLC (GB) | 2003-12-31 | — | — | WO | disclosed |
| EP-0971997-B1 | HARD-SURFACE CLEANING COMPOSITIONS | UNILEVER PLC (GB) | 2003-07-23 | — | — | EP | disclosed |
| EP-0971997-A1 | HARD-SURFACE CLEANING COMPOSITIONS | UNILEVER PLC (GB) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998040452-A1 | HARD-SURFACE CLEANING COMPOSITIONS | UNILEVER PLC (GB) | 1998-09-17 | — | — | WO | disclosed |
| US-4194915-A | Foundry mold and core wash additives | N L INDUSTRIES, INC. (US) | 1980-03-25 | — | — | US | disclosed |
| US-4063950-A | DEVELOPMENT INHIBITOR RELEASING COMPOUND, SILVER HALIDE EMULSIONS ON | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050232892-A1 | Hair conditioning composition | H1-10, SLC9A1, ASH2L | DNM1 2543/4885ALDH1A1 419/4885TP53 2987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.